News Home

Can Kiniksa Pharmaceuticals Ltd (KNSA) Stock Rise to the Top of Healthcare Sector Tuesday?

Tuesday, February 23, 2021 02:24 PM | InvestorsObserver Analysts
Can Kiniksa Pharmaceuticals Ltd (KNSA) Stock Rise to the Top of Healthcare Sector Tuesday?

Kiniksa Pharmaceuticals Ltd (KNSA) is near the top in its sector according to InvestorsObserver.

KNSA gets an overall rating of 57. That means it scores higher than 57% of stocks.

Kiniksa Pharmaceuticals Ltd gets a 80 rank in the Healthcare sector. Healthcare is number 2 out of 11 sectors.

Overall Score - 57
KNSA has an Overall Score of 57. Find out what this means to you and get the rest of the rankings on KNSA!

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 57 means the stock is more attractive than 57 percent of stocks.

Not only are these scores easy to understand, but it is easy to compare stocks to each other. You can find the best stock in healthcare or look for the sector that has the highest average score.

The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Kiniksa Pharmaceuticals Ltd Stock Today?

Kiniksa Pharmaceuticals Ltd (KNSA) stock is trading at $21.75 as of 2:20 PM on Tuesday, Feb 23, a loss of -$1.59, or -6.83% from the previous closing price of $23.34. The stock has traded between $21.61 and $23.22 so far today. Volume today is 327,776 compared to average volume of 321,597.

Click Here to get the full Stock Score Report on Kiniksa Pharmaceuticals Ltd (KNSA) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App